← Back
$AKTS All transactions

Aktis Oncology, Inc.

C

$ Value

Shares

128,506

Price

Filed

Jan 12

Insider

Name

EcoR1 Capital, LLC

Title

CIK

0001587114

Roles

Director

Transaction Details

Transaction Date

2026-01-12

Code

C

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

128,506

Footnotes

The shares of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock converted into shares of Common Stock and Class A Common Stock on a 3.8044-for-1 basis immediately prior to the closing of the initial public offering of the Issuer's Common Stock for no additional consideration. Each share was immediately exercisable and had no expiration date. | These securities are held by EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 Capital, LLC ("EcoR1") may be deemed to indirectly beneficially own them as the investment adviser to and general partner of the fund. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. | These securities are held by EcoR1 Capital Fund, L.P. ("Capital Fund"). EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to and general partner of the fund. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. | These securities are held by EcoR1 Venture Opportunity Fund, L.P. ("Venture Fund"). EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to and general partner of the fund. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. | Each share of Class A Common Stock is convertible into one share of Common Stock at the election of the holder for no additional consideration, subject to a 4.99% beneficial ownership limitation. Each share is immediately exercisable and has no expiration date.

Filing Info

Accession No.

0000935836-26-000031

Form Type

4

Issuer CIK

0002035832

EcoR1 Capital, LLC's History

Date Ticker Type Value
2026-04-20 TRAX $65.0M
2026-01-12 AKTS C
2026-01-12 AKTS C
2026-01-12 AKTS C
2026-01-12 AKTS $37.4M
2026-01-12 AKTS $2.6M
2026-01-12 AKTS C
2026-01-12 AKTS C
2026-01-12 AKTS C
2026-01-12 AKTS C

Other Insiders at AKTS (90d)

Insider Bought Sold Last
Gormley Glenn 2026-04-15